Table 7.

Antibacterial DKPs.

Entry	Structure	Name	Bacterial Strains	MIC [μg/mL]	Reference
1.		cyclo(l-Leu-l-Pro)	Enterococcus faecalis (VRE) Micrococcus luteus, Staphylococcus aureus	12.5	[214]
				2.9 mmol/L	[218]
2.		cyclo(l-Phe-l-Pro)	Micrococcus luteus, Staphylococcus aureus Staphylococcus aureus	2.9 mmol/L	[218]
				10 mm zone of inhibition	[222]
3.		Combination of cyclo(l-Leu-l-Pro) and cyclo(l-Phe-l-Pro)	Enterococcus faecalis (VRE) Micrococcus luteus, Escherichia coli, Candida albicans, Staphylococcus aureus, Cryptococcus neoformans	0.25–1	[215]
				0.25–0.5	[215]
4.		cyclo(l-Pro-l-Pro)	Pseudomonas aeruginosa	150 AU/mL	[219]
			Micrococcus luteus	100 AU/mL	[219]
5.		Avrainvillamide	Staphylococcus aureus	12.5	[87]
			Streptococcus pyogenes	12.5	[87]
			Enterococcus faecalis	25	[87]
6.		Speramide A	Pseudomonas aeruginosa	0.36	[41]
7.		Fumitremorgin C	Staphylococcus aureus Bacillus subtilis	2.1–3.3	[41]
8.		Tryprostatin B	Staphylococcus aureus Bacillus subtilis	2.1–3.3	[41]
9.		Brevianamide F, cyclo(l-Trp-l-Pro)	Micrococcus luteus Staphylococcus aureus	Reported as zones of inhibition of 14 mm	[216]
10.		cyclo(l-Phe-d-Pro)	Vibrio anguillarum	0.10	[220]
			Staphylococcus aureus	14 mm zone of inhibition	[108]
11.		cyclo(d-Phe-d-Pro)	Vibrio anguillarum	0.03	[220]